意大利急诊医师在急诊科实施程序性镇静:SEED SIMEU 登记研究结果
该研究为意大利10家急诊科2019至2022年的程序性镇静登记研究,纳入1349例成人患者,此前对工作人员进行了专门培训并采用标准化方案。66.3%的镇静用于电复律,23.2%用于骨科操作,丙泊酚(67%)和咪达唑仑(24.2%)是最常用镇静药,70.6%患者达到深度镇静。操作失败率4.6%,操作相关疼痛回忆率2.6%,操作回忆率2.9%;不良事件总发生率10%(轻微2.8%、次要2.8%、中度4.4%),无需要非计划入院或升级治疗的不良事件,无哨兵事件。不良事件发生率在高ASA分级、中/困难气道和更深镇静水平时更高。
要点
- 1349例成人急诊程序性镇静中,操作失败率4.6%,不同操作类型或药物间无显著差异。
- 丙泊酚(67%)和咪达唑仑(24.2%)为最常用镇静药,70.6%患者达到深度镇静水平。
- 操作回忆率2.9%、操作相关疼痛率2.6%,二者更常见于骨科操作、使用咪达唑仑(与丙泊酚相比)及较浅镇静水平。
- 不良事件总发生率10%(轻微2.8%、次要2.8%、中度4.4%),无需要非计划入院或升级治疗的不良事件,无哨兵事件,全部经简单无创处理缓解。
- 不良事件发生率在高ASA分级、中/困难气道和更深镇静水平时更高;作者结论认为急诊医师以丙泊酚为主的程序性镇静有效且安全,不良事件率与既往国际研究相当。
适用人群与场景
- 意大利10家急诊科收治的成人患者,2019至2022年接受程序性镇静;研究前对工作人员进行了专门培训并采用标准化方案。
诊断标准与关键阈值
- 镇静深度记录为预定义和实际镇静水平,70.6%患者达到深度镇静水平。
- 不良事件按世界静脉麻醉学会(World Society of Intravenous Anaesthesia)标准分类为轻微、次要和中度。
处置流程与药物剂量
- 镇静药物以丙泊酚(67%)和咪达唑仑(24.2%)最常用;原文未报告具体剂量、给药途径和频次。
- 镇静适应证包括电复律(66.3%)、骨科操作(23.2%)和其他操作(10.5%)。
红旗征与不能漏的情况
- 高美国麻醉医师学会(ASA)分级、中/困难气道和更深镇静水平时不良事件发生率更高。
研究设计与关键结果
- 研究类型为登记研究,纳入10家意大利急诊科1349例成人患者,中位年龄68岁,男性64%。
- 操作失败率4.6%,不同操作类型或所用药物间无显著差异。
- 操作回忆率2.9%,操作相关疼痛率2.6%,二者更常见于骨科操作、使用咪达唑仑(与丙泊酚相比)及较浅镇静水平。
- 共观察到135例不良事件,总发生率10%:轻微38例(2.8%)、次要38例(2.8%)、中度59例(4.4%);无需要非计划入院或升级治疗的不良事件,无哨兵事件,全部经简单无创处理缓解。
- 不良事件发生率在高ASA分级、中/困难气道和更深镇静水平时更高。
证据类型、等级与局限
- 证据类型:多中心登记研究;原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,意大利急诊医师以丙泊酚为主要镇静药实施的程序性镇静有效且安全,不良事件率与既往国际研究相当。
- 原文报告高ASA分级、中/困难气道和更深镇静水平与更高不良事件发生率相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND AND IMPORTANCE: Effective and safe procedural sedation is pivotal for the quality of care in the emergency department (ED).
OBJECTIVES: The aim of this work is to evaluate the feasibility, effectiveness, and safety procedural sedation performed by emergency physicians in the ED setting in Italy.
DESIGN/SETTING AND PARTICIPANTS/INTERVENTION: Following a specific training of the staff and with the adoption of a standardized protocol, a registry of procedural sedations performed on adult patients in 10 Italian EDs was compiled from 2019 to 2022; the following basic data were recorded: demographic and clinical information, procedure's indication, administered drugs, predefined, and actual sedation level.
OUTCOME MEASURES AND ANALYSIS: Effectiveness was evaluated considering three parameters: successful completion of the procedure, absence of procedural pain, and no memory of the procedure; adverse events were classified according to the World Society of Intravenous Anaesthesia criteria and evaluated taking into account clinical and procedural variables.
MAIN RESULTS: The study included 1349 patients (median age 68 years, male 64%). Sedation was performed for electrical cardioversion (66.3%), orthopedic procedures (23.2%), or other procedures (10.5%). Propofol (67%) and midazolam (24.2%) were the two most frequently used sedatives and 70.6% of the patients achieved a deep level of sedation.Procedural failure occurred in 4.6% of cases, with no significant differences between procedure types or drugs used. Recall of the procedure and procedural related pain were reported by 2.9% and 2.6% of patients, respectively, and were more frequently related to orthopedic procedures, midazolam use - if compared with propofol, and lower levels of sedation.A total of 135 adverse events were observed, with an overall incidence of 10%: 38 minimal adverse events (2.8%), 38 minor adverse events (2.8%), and 59 moderate adverse events (4.4%). There were no adverse events requiring unplanned hospital admission or escalation of care, and no sentinel adverse events were observed. All adverse events were resolved with simple and noninvasive treatments. The incidence of adverse events was greater with higher American Society of Anesthesiologists class, intermediate/difficult airway, and deeper sedation levels.
CONCLUSION: Procedural sedation performed in Italian EDs by emergency physicians, with propofol as main sedative, was effective and safe, and has comparable adverse event rates with previous international studies.
参考来源
- Lison D, Lorenzati B, Segre E, et al. Procedural sedation in the emergency department by Italian emergency physicians: results of the SEED SIMEU registry. Eur J Emerg Med. 2024. PMID: 39715053. doi:10.1097/MEJ.0000000000001210
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。